Glioblastoma: Clinical characteristics, prognostic factors and survival in 492 patients
暂无分享,去创建一个
Arya Nabavi | Andreas M. Stark | H. Maximilian Mehdorn | H. Mehdorn | A. Nabavi | J. Hedderich | Jürgen Hedderich | Julia van de Bergh | A. Stark | J. Bergh | Julia van de Bergh
[1] Mitchel S Berger,et al. An extent of resection threshold for newly diagnosed glioblastomas. , 2011, Journal of neurosurgery.
[2] L. Welling,et al. Prognostic factors in glioblastoma multiforme , 2010, Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery.
[3] Susan M. Chang,et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Tao Jiang,et al. Prognostic factors influencing clinical outcomes of glioblastoma multiforme. , 2009, Chinese medical journal.
[5] D. Brat,et al. Management of newly diagnosed glioblastoma: guidelines development, value and application , 2009, Journal of Neuro-Oncology.
[6] Henry Brem,et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. , 2009, Journal of neurosurgery.
[7] Veit Rohde,et al. EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME: IDENTIFICATION OF AND ADJUSTMENT FOR BIAS , 2008, Neurosurgery.
[8] D. Caldiroli,et al. Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. , 2008, Neuro-oncology.
[9] H. Mehdorn,et al. Glioblastoma—the consequences of advanced patient age on treatment and survival , 2006, Neurosurgical Review.
[10] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[11] R. Mirimanoff,et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.
[12] H. Mehdorn,et al. Glioblastoma multiforme-report of 267 cases treated at a single institution. , 2005, Surgical neurology.
[13] Kenneth R. Hess,et al. Extent of Resection as a Prognostic Variable in the Treatment of Gliomas , 1999, Journal of Neuro-Oncology.
[14] L. Cervoni,et al. Long-term survival in patients with supratentorial glioblastoma , 2004, Journal of Neuro-Oncology.
[15] A. Frati,et al. Multicentric glioma: our experience in 25 patients and critical review of the literature , 2003, Neurosurgical Review.
[16] W. Sauerbrei,et al. Multivariate Analysis of Prognostic Factors in Patients with Glioblastoma , 2003, Strahlentherapie und Onkologie.
[17] Z L Gokaslan,et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.
[18] M. Hulshof,et al. Prognostic Factors in Glioblastoma Multiforme 10 Years Experience of a Single Institution , 2001, Strahlentherapie und Onkologie.
[19] K. Fujii,et al. Clinical cure of glioblastoma--two case reports. , 2000, Neurologia medico-chirurgica.
[20] Webster K. Cavenee,et al. Pathology and genetics of tumours of the nervous system. , 2000 .
[21] J. Cairncross,et al. Which glioblastoma multiforme patient will become a long‐term survivor? A population‐based study , 1999, Annals of neurology.
[22] P. Kleihues,et al. Primary and secondary glioblastomas: from concept to clinical diagnosis. , 1999, Neuro-oncology.
[23] P. Forsyth,et al. Long-term Glioblastoma Multiforme Survivors: a Population-based Study , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[24] S. Brem,et al. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. , 1998, Journal of neurosurgery.
[25] H. Thames,et al. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. , 1997, International journal of radiation oncology, biology, physics.
[26] D. Louis,et al. Molecular pathways in the formation of gliomas , 1995, Glia.
[27] S. Leeder,et al. A population based study , 1993, The Medical journal of Australia.
[28] M. Bernstein,et al. The value of reoperation for recurrent glioblastoma. , 1993, Canadian journal of surgery. Journal canadien de chirurgie.
[29] P. Gutin,et al. Reoperation for recurrent glioblastoma and anaplastic astrocytoma. , 1987, Neurosurgery.
[30] W. Markesbery,et al. Reoperation for glioblastoma. , 1981, Journal of neurosurgery.
[31] N. Malamud,et al. THE PROBLEM OF MULTICENTRIC GLIOMAS. , 1963, Journal of neurosurgery.
[32] Colin M. MacLeod,et al. Evaluation of chemotherapeutic agents , 1949 .
[33] E. B. Jackson,et al. Effects of Colchicine and Radiation on Growth of Normal Tissues and Tumors , 1940 .